Literature DB >> 20482463

Tissue engineered tumor models.

M Ingram1, G B Techy, B R Ward, S A Imam, R Atkinson, H Ho, C R Taylor.   

Abstract

Many research programs use well-characterized tumor cell lines as tumor models for in vitro studies. Because tumor cells grown as three-dimensional (3-D) structures have been shown to behave more like tumors in vivo than do cells growing in monolayer culture, a growing number of investigators now use tumor cell spheroids as models. Single cell type spheroids, however, do not model the stromal-epithelial interactions that have an important role in controlling tumor growth and development in vivo. We describe here a method for generating, reproducibly, more realistic 3-D tumor models that contain both stromal and malignant epithelial cells with an architecture that closely resembles that of tumor microlesions in vivo. Because they are so tissue-like we refer to them as tumor histoids. They can be generated reproducibly in substantial quantities. The bioreactor developed to generate histoid constructs is described and illustrated. It accommodates disposable culture chambers that have filled volumes of either 10 or 64 ml, each culture yielding on the order of 100 or 600 histoid particles, respectively. Each particle is a few tenths of a millimeter in diameter. Examples of histological sections of tumor histoids representing cancers of breast, prostate, colon, pancreas and urinary bladder are presented. Potential applications of tumor histoids include, but are not limited to, use as surrogate tumors for pre-screening anti-solid tumor pharmaceutical agents, as reference specimens for immunostaining in the surgical pathology laboratory and use in studies of invasive properties of cells or other aspects of tumor development and progression. Histoids containing nonmalignant cells also may have potential as "seeds" in tissue engineering. For drug testing, histoids probably will have to meet certain criteria of size and tumor cell content. Using a COPAS Plus flow cytometer, histoids containing fluorescent tumor cells were analyzed successfully and sorted using such criteria.

Entities:  

Mesh:

Year:  2010        PMID: 20482463     DOI: 10.3109/10520295.2010.483655

Source DB:  PubMed          Journal:  Biotech Histochem        ISSN: 1052-0295            Impact factor:   1.718


  7 in total

Review 1.  Review of collagen I hydrogels for bioengineered tissue microenvironments: characterization of mechanics, structure, and transport.

Authors:  Elizabeth E Antoine; Pavlos P Vlachos; Marissa Nichole Rylander
Journal:  Tissue Eng Part B Rev       Date:  2014-07-22       Impact factor: 6.389

2.  Human breast cancer histoid: an in vitro 3-dimensional co-culture model that mimics breast cancer tissue.

Authors:  Pavinder Kaur; Brenda Ward; Baisakhi Saha; Lillian Young; Susan Groshen; Geza Techy; Yani Lu; Roscoe Atkinson; Clive R Taylor; Marylou Ingram; S Ashraf Imam
Journal:  J Histochem Cytochem       Date:  2011-10-27       Impact factor: 2.479

Review 3.  Opportunities and challenges for use of tumor spheroids as models to test drug delivery and efficacy.

Authors:  Geeta Mehta; Amy Y Hsiao; Marylou Ingram; Gary D Luker; Shuichi Takayama
Journal:  J Control Release       Date:  2012-05-18       Impact factor: 9.776

4.  An update to space biomedical research: tissue engineering in microgravity bioreactors.

Authors:  Abolfazl Barzegari; Amir Ata Saei
Journal:  Bioimpacts       Date:  2012-03-16

Review 5.  Recapitulating the Tumor Ecosystem Along the Metastatic Cascade Using 3D Culture Models.

Authors:  Jiyun Kim; Kandice Tanner
Journal:  Front Oncol       Date:  2015-07-29       Impact factor: 6.244

6.  Flow measurements in a blood-perfused collagen vessel using x-ray micro-particle image velocimetry.

Authors:  Elizabeth Antoine; Cara Buchanan; Kamel Fezzaa; Wah-Keat Lee; M Nichole Rylander; Pavlos Vlachos
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

7.  Development of three-dimensional lung multicellular spheroids in air- and liquid-interface culture for the evaluation of anticancer therapeutics.

Authors:  Samantha A Meenach; Alexandra N Tsoras; Ronald C McGarry; Heidi M Mansour; J Zach Hilt; Kimberly W Anderson
Journal:  Int J Oncol       Date:  2016-02-04       Impact factor: 5.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.